Pharmacology of Non-Dihydropyridine CCBs
10 Questions
0 Views

Pharmacology of Non-Dihydropyridine CCBs

Created by
@ResilientFractal

Questions and Answers

What is the primary purpose of administering fresh-frozen plasma or clotting factor concentrates in life-threatening bleeding?

  • To provide essential nutrients
  • To restore normal clotting function (correct)
  • To promote wound healing
  • To replenish lost blood volume
  • Which of the following is NOT a characteristic of direct oral anticoagulants compared to warfarin?

  • Less need for routine monitoring
  • Longer half-life (correct)
  • More rapid onset
  • Wider therapeutic window
  • Which direct oral anticoagulant requires prior subcutaneous anticoagulation for at least 5 days before its administration?

  • Edoxaban (correct)
  • Rivaroxaban
  • Apixaban
  • Dabigatran (correct)
  • What is the role of idarucizumab in anticoagulation therapy?

    <p>To reverse dabigatran anticoagulation</p> Signup and view all the answers

    What is a common advantage of using fondaparinux over low molecular weight heparin (LMWH)?

    <p>It is safer and more effective for VTE treatment</p> Signup and view all the answers

    Which of the following is true regarding parenteral direct thrombin inhibitors (DTIs)?

    <p>They are preferred for treating VTE in patients with HIT</p> Signup and view all the answers

    Which of the following anticoagulants does NOT require any routine monitoring?

    <p>Rivaroxaban</p> Signup and view all the answers

    Which characteristic helps differentiate direct oral anticoagulants from traditional anticoagulants like warfarin?

    <p>Rapid onset of action</p> Signup and view all the answers

    What does andexanet alfa do?

    <p>It reverses the anticoagulant effects of apixaban and rivaroxaban</p> Signup and view all the answers

    Which anticoagulant is categorized as a direct thrombin inhibitor?

    <p>Dabigatran</p> Signup and view all the answers

    Study Notes

    Calcium Channel Blockers (CCBs)

    • Non-dihydropyridine CCBs, such as diltiazem and verapamil, are more selective for cardiac tissues compared to vascular smooth muscle.
    • Verapamil significantly decreases heart rate; diltiazem has a lesser effect.
    • CCBs are primarily used for managing angina pectoris and hypertension, with non-dihydropyridines also treating cardiac arrhythmias.
    • Effective in treating angina linked to coronary vasospasm.
    • Nimodipine, related to nifedipine, specifically targets cerebral arteries for vascular spasms post-aneurysmal subarachnoid hemorrhage.
    • Verapamil is indicated for cluster headache and migraine prophylaxis; nifedipine treats Raynaud’s syndrome and chronic anal fissure.
    • Amlodipine and felodipine allow once-daily dosing due to their extended duration of action.
    • Common side effects include flushing, headache, and ankle swelling; verapamil is known for causing constipation.
    • Amlodipine and other CCBs should generally be avoided in patients with heart failure as they may worsen cardiac function.

    Lipid-Regulating Drugs

    • Designed to modify blood lipid levels, helping manage dyslipidemias and reduce cardiovascular risks.
    • Main classes of lipid-regulating drugs include:
      • Statins (e.g., atorvastatin, rosuvastatin)
      • Fibrates (e.g., fenofibrate, gemfibrozil)
      • Nicotinic acid (e.g., acipimox)
      • Bile acid sequestrants (e.g., colesevelam)
      • Absorption inhibitors (e.g., ezetimibe)
      • Others (e.g., alirocumab, evolocumab)
    • Statins block HMG-CoA reductase, crucial in cholesterol synthesis, effectively lowering LDL but less effective than fibrates for triglycerides.
    • Statins are used for primary and secondary prevention in dyslipidemia with documented coronary artery disease.
    • Rosuvastatin and atorvastatin have the longest half-lives and are preferred due to lower hepatotoxicity risks.
    • Omega-3 fatty acids can reduce triglyceride levels significantly and are utilized as adjunct therapy in hypertriglyceridemia.
    • PCSK9 inhibitors (alirocumab, evolocumab) can reduce LDL-C by up to 60% in combination with statins, administered subcutaneously.
    • Lomitapide and mipomersen are for homozygous familial hypercholesterolemia and have black box warnings for hepatotoxicity.
    • Bempedoic acid lowers LDL-cholesterol and is indicated for inadequate responses to other therapies.

    Nitrates

    • Nitrates are vasodilators used for angina pectoris, heart failure, myocardial infarction, and anal fissures.
    • Sublingual Glyceryl Trinitrate (GTN) offers rapid relief from angina; aerosol sprays are alternatives for ease of use.
    • Proper usage involves placement under the tongue without swallowing or inhaling.
    • Patient instructions for managing acute angina include rest, GTN administration, and seeking medical help if pain persists after three doses in 15 minutes.

    Direct Oral Anticoagulants (DOACs)

    • Categories include direct thrombin inhibitors (e.g., dabigatran) and direct factor Xa inhibitors (e.g., rivaroxaban, apixaban).
    • DOACs provide rapid onset, predictable pharmacokinetics, and eliminate the need for routine monitoring compared to warfarin.
    • For treating or preventing recurrent VTE, edoxaban and dabigatran require initial treatment with parenteral anticoagulants for five days.
    • Lower risks of intracranial hemorrhage are associated with target-specific anticoagulants.
    • Idarucizumab reverses dabigatran effects, while andexanet alfa reverses apixaban and rivaroxaban effects.

    Parenteral Anticoagulants

    • Injectable direct thrombin inhibitors include lepirudin, bivalirudin, argatroban, and desirudin; they are preferred in patients with a history of heparin-induced thrombocytopenia (HIT).
    • Fondaparinux serves as an effective alternative to low molecular weight heparin (LMWH) for VTE treatment and prevention after surgery without routine coagulation testing requirements.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    This quiz explores the pharmacological properties and clinical uses of non-dihydropyridine calcium channel blockers (CCBs), specifically diltiazem and verapamil. Learn how these medications affect heart rate and their applications in conditions like angina pectoris and hypertension.

    More Quizzes Like This

    Skeletal Muscle Calcium Ion Flux
    10 questions
    Use Quizgecko on...
    Browser
    Browser